NO144108C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamiderInfo
- Publication number
- NO144108C NO144108C NO750957A NO750957A NO144108C NO 144108 C NO144108 C NO 144108C NO 750957 A NO750957 A NO 750957A NO 750957 A NO750957 A NO 750957A NO 144108 C NO144108 C NO 144108C
- Authority
- NO
- Norway
- Prior art keywords
- benzylpiperid
- benzamides
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB12572/74A GB1507462A (en) | 1974-03-21 | 1974-03-21 | N-heterocyclic substituted benzamides methods for their preparation and compositions containing them |
GB3540274 | 1974-08-12 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO750957L NO750957L (fr) | 1975-09-23 |
NO144108B NO144108B (no) | 1981-03-16 |
NO144108C true NO144108C (no) | 1981-06-24 |
Family
ID=26249107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO750957A NO144108C (no) | 1974-03-21 | 1975-03-20 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider |
Country Status (11)
Country | Link |
---|---|
JP (1) | JPS584019B2 (fr) |
AR (1) | AR216043A1 (fr) |
CH (1) | CH602641A5 (fr) |
DK (1) | DK147854C (fr) |
ES (5) | ES435756A1 (fr) |
FI (1) | FI60200C (fr) |
FR (1) | FR2264530A1 (fr) |
KE (1) | KE2900A (fr) |
NL (1) | NL159660B (fr) |
NO (1) | NO144108C (fr) |
SE (1) | SE427750B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1513631A (en) * | 1976-02-17 | 1978-06-07 | Gallardo Antonio Sa | Piperidine derivatives |
GB1561023A (en) * | 1977-04-22 | 1980-02-13 | Beecham Group Ltd | 2-methoxy - 5 - chloro aniline derivatives |
FR2446274A1 (fr) * | 1979-01-15 | 1980-08-08 | Delalande Sa | Nouveaux derives de salicylamide, leur procede de preparation et leur application en therapeutique |
EP0343307A1 (fr) * | 1988-05-26 | 1989-11-29 | Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. | Dérivés de 4-pipéridinealcanamine |
FR2674849B1 (fr) * | 1991-04-02 | 1994-12-23 | Logeais Labor Jacques | Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique. |
FR2766484B1 (fr) * | 1997-07-25 | 1999-09-17 | Logeais Labor Jacques | Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse |
FR2766486B1 (fr) * | 1997-07-25 | 1999-09-17 | Logeais Labor Jacques | Cycloalkyles benzamides stimulants de la motricite gastrointestinale haute et basse |
RU2403250C2 (ru) * | 2005-06-02 | 2010-11-10 | Ф.Хоффманн-Ля Рош Аг | Производные пиперидин-4-иламида и их применение в качестве антагонистов рецептора sst подтипа 5 |
KR100976063B1 (ko) * | 2007-03-16 | 2010-08-17 | 동아제약주식회사 | 신규한 벤즈아미드 유도체 화합물 및 그의 제조방법 |
ES2668841T3 (es) * | 2011-11-29 | 2018-05-22 | Vivozon Inc. | Derivado novedoso de benzamida y uso del mismo |
-
1975
- 1975-03-17 AR AR257994A patent/AR216043A1/es active
- 1975-03-18 ES ES435756A patent/ES435756A1/es not_active Expired
- 1975-03-18 ES ES435754A patent/ES435754A1/es not_active Expired
- 1975-03-18 ES ES435753A patent/ES435753A1/es not_active Expired
- 1975-03-18 ES ES435757A patent/ES435757A1/es not_active Expired
- 1975-03-18 ES ES435755A patent/ES435755A1/es not_active Expired
- 1975-03-20 CH CH355075A patent/CH602641A5/xx not_active IP Right Cessation
- 1975-03-20 FR FR7509371A patent/FR2264530A1/fr active Granted
- 1975-03-20 SE SE7503196A patent/SE427750B/xx not_active IP Right Cessation
- 1975-03-20 DK DK117675A patent/DK147854C/da not_active IP Right Cessation
- 1975-03-20 NO NO750957A patent/NO144108C/no unknown
- 1975-03-20 FI FI750825A patent/FI60200C/fi not_active IP Right Cessation
- 1975-03-21 NL NL7503417.A patent/NL159660B/xx not_active IP Right Cessation
- 1975-03-22 JP JP7534871A patent/JPS584019B2/ja not_active Expired
-
1978
- 1978-11-14 KE KE2900A patent/KE2900A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
SE427750B (sv) | 1983-05-02 |
FI750825A (fr) | 1975-09-22 |
ES435757A1 (es) | 1977-04-01 |
JPS50129573A (fr) | 1975-10-13 |
CH602641A5 (fr) | 1978-07-31 |
SE7503196L (fr) | 1975-09-22 |
FR2264530A1 (en) | 1975-10-17 |
AR216043A1 (es) | 1979-11-30 |
DK117675A (fr) | 1975-09-22 |
NL7503417A (nl) | 1975-09-23 |
JPS584019B2 (ja) | 1983-01-24 |
NO750957L (fr) | 1975-09-23 |
DK147854B (da) | 1984-12-24 |
FI60200B (fi) | 1981-08-31 |
ES435756A1 (es) | 1977-04-01 |
DK147854C (da) | 1985-07-22 |
NL159660B (nl) | 1979-03-15 |
ES435754A1 (es) | 1977-04-01 |
ES435755A1 (es) | 1977-04-01 |
KE2900A (en) | 1978-12-01 |
FI60200C (fi) | 1981-12-10 |
FR2264530B1 (fr) | 1978-11-10 |
NO144108B (no) | 1981-03-16 |
ES435753A1 (es) | 1977-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO143576C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser | |
NO144262C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme n-substituerte benzamidderivater | |
NO149106C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider | |
NO145691C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider | |
NO141407C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater | |
NO143460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
NO141800C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
NO151040C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner | |
NO147109C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive diazepin-derivater | |
NO146359C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater | |
NO142838C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater | |
NO144108C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider | |
NO141894C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner | |
NO143064C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner | |
NO140824C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener | |
NO142077C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider | |
NO143664C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive dibenzofuranforbindelser | |
NO147485C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater | |
NO145163C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider | |
NO145238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater | |
NO144704C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-alkyl-2-(fenoksymetyl)-5-nitro-imidazoler | |
NO146672C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater | |
NO143903C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater | |
NO144741C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler | |
SE414028B (sv) | Forfarande for framstellning av terapeutisk verksamma fentiazinderivat |